These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

277 related articles for article (PubMed ID: 7249439)

  • 1. Treatment of advanced oestrogen-resistant prostatic carcinoma with estramustine phosphate.
    Wong AL; McGeorge A; Abel BJ
    Clin Oncol; 1981 Jun; 7(2):163-5. PubMed ID: 7249439
    [No Abstract]   [Full Text] [Related]  

  • 2. [Treatment of advanced estrogen-resistant cancer of the prostate with estramustine phosphate. A phase-2 study].
    Trykker HU
    Ugeskr Laeger; 1985 Oct; 147(42):3310-2. PubMed ID: 4082315
    [No Abstract]   [Full Text] [Related]  

  • 3. [Experiences with estramustinphosphate (Estracyt) in estrogen-resistant metastasizing prostatic cancer].
    Köller A; Lunglmayr G
    Wien Med Wochenschr; 1983; 133(7):179-81. PubMed ID: 6868629
    [No Abstract]   [Full Text] [Related]  

  • 4. [Treatment of hormone-resistant prostate cancer with estramustine phosphate (Estracyt)].
    Stridsklev IC; Fosså SD; Kaalhus O
    Tidsskr Nor Laegeforen; 1984 Oct; 104(28):1977-80. PubMed ID: 6388019
    [No Abstract]   [Full Text] [Related]  

  • 5. [Treatment of advanced carcinoma of the prostate with estramustine phosphate (estracyt)].
    Lancina Martín JA; Chantada Abal V; Lamas Meilan AC; González Martín M
    Actas Urol Esp; 1984; 8(5):399-402. PubMed ID: 6524487
    [No Abstract]   [Full Text] [Related]  

  • 6. [Value of estramustine phosphate in the treatment of estrogen-resistant prostatic adenocarcinoma].
    Toulouse J; Jung JL; Bittard M
    J Urol (Paris); 1984; 90(1):27-33. PubMed ID: 6725973
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Treatment of prostatic carcinoma with estramustine phosphate (Estracyt).
    Benson RC
    Wis Med J; 1976 Sep; 75(9):S89-90. PubMed ID: 969557
    [No Abstract]   [Full Text] [Related]  

  • 8. [Treatment of advanced prostatic carcinoma using estramustinphosphate].
    Ferrer Roda J
    Actas Urol Esp; 1983; 7(1):29-34. PubMed ID: 6192690
    [No Abstract]   [Full Text] [Related]  

  • 9. Oral estramustine phosphate. Prolonged therapy for advanced carcinoma of prostate.
    Catane R; Mittelman A; Kaufman J; Murphy GP
    N Y State J Med; 1976 Nov; 76(12):1978-81. PubMed ID: 1069190
    [No Abstract]   [Full Text] [Related]  

  • 10. The treatment of oestrogen-escaped carcinoma of the prostate with estramustine phosphate.
    Chisholm GD; O'Donoghue EP; Kennedy CL
    Br J Urol; 1977; 49(7):717-20. PubMed ID: 339986
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Oral estramustine phosphate (Estracyt): a broad phase II study.
    Halpern J; Catane R
    J Med; 1984; 15(1):35-43. PubMed ID: 6593404
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Treatment of advanced carcinoma of the prostate with estramustine phosphate.
    Fosså SD; Miller A
    J Urol; 1976 Apr; 115(4):406-8. PubMed ID: 1263316
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Treatment of advanced carcinoma of the prostate with Estracyt.
    Nagel R; Kölln CP
    Prog Clin Biol Res; 1976; 6():267-84. PubMed ID: 1023214
    [No Abstract]   [Full Text] [Related]  

  • 14. [Clinical study of estramustine phosphate (Estracyt) on prostatic cancer].
    Murase T; Mitsuya H; Honda N; Fukatu H; Aota Y; Shinoda M; Yoshida K; Sobajima T; Ohishi M; Tsumura Y
    Hinyokika Kiyo; 1989 Jan; 35(1):179-85. PubMed ID: 2729015
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Estramustine phosphate in prostate cancer. Seminar.
    Urology; 1984 Jun; 23(6 Suppl):1-88. PubMed ID: 6730139
    [No Abstract]   [Full Text] [Related]  

  • 16. [Plasma changes caused by estrogens in the vascular risk of prostatic carcinoma over a 3-year period].
    Daponte DP; Stevens I; Robinson MR
    Actas Urol Esp; 1986; 10(6):437-40. PubMed ID: 3825644
    [No Abstract]   [Full Text] [Related]  

  • 17. Experience with estramustine phosphate.
    Nilsson T; Wear JB
    Wis Med J; 1976 Nov; 75(11):S121-S123. PubMed ID: 1007313
    [No Abstract]   [Full Text] [Related]  

  • 18. Estramustine phosphate therapy in poorly differentiated carcinoma of the prostate.
    Edsmyr F; Esposti PL; Andersson L
    Scand J Urol Nephrol Suppl; 1980; 55():139-42. PubMed ID: 6938017
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Estracyt and radiotherapy in the treatment of prostatic cancer].
    Van Regemorter G; Germeau F
    Acta Urol Belg; 1980 Jan; 48(1):138-48. PubMed ID: 7435350
    [No Abstract]   [Full Text] [Related]  

  • 20. [Estracyt treatment in prostatic neoplasms].
    Sander S
    Tidsskr Nor Laegeforen; 1976 Jan; 96(1):27-8. PubMed ID: 1257949
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 14.